COURSE DIRECTOR
Nabeel Aslam

DESCRIPTION
Through a combination of case-based presentations and literature review, the nephrology education series delivers up-to-date and cutting-edge information that can be directly integrated into clinical practice in the fields of nephrology and hypertension. This course is intended for members of the nephrology and hypertension at the Mayo Clinic Florida and is of interest to nephrologists, nephrology trainees, and nurse practitioners. 

TARGET AUDIENCE
This course is intended primarily for Nephrology & Hypertension Physicians, fellows, NPs, PAs, and Nurses.

LEARNING OBJECTIVES
Upon completion of this activity, participants should be able to:

• Discuss the presented nephrology topic (pathogenesis, clinical presentation, diagnostic evaluation) and its relevance to clinical practice.
• Explain the most up-to-date management options literature as it relates to the discussion topic.

Accreditation Statement
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Credit Statement(s):
AMA
Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ANCC
Mayo Clinic College of Medicine and Science designates this activity for a maximum of 1.00 ANCC contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

DISCLOSURE SUMMARY
As a provider accredited by Joint Accreditation for Interprofessional Continuing Education, Mayo Clinic College of Medicine and Science must ensure balance, independence, objectivity and scientific rigor in its educational activities.  All who are in a position to control the content are required to disclose all financial relationships with any ineligible company.   Faculty will also identify any off-label and/or investigational use of pharmaceuticals or instruments discussed in their content for FDA compliance.

Listed below are individuals with control of the content of this program who have disclosed...

Relevant financial relationship(s) with ineligible companies: 
Nabeel Aslam, M.D – Intellectual Property: Light Line Medical; Honoraria: Amgen, Inc., Chinook Therapeutics, Inc., Travere Therapeutics, Inc., Novartis Pharmaceuticals Corporation; Grant: Novartis, Otsuka

All relevant financial relationships listed for these individuals have been mitigated.

No relevant financial relationship(s) with ineligible companies: 
LaTonya J. Hickson, M.D.
Ivan E. Porter II, M.D.
Leslie H. Quinn, M.B.A.
LaKesha N. Spicer, APRN
Christopher L. Trautman, M.D.
Taylor Y. Avrett (Coordinator)
Jennifer A. King (Coordinator)

References to off-label usage(s) of pharmaceuticals or instruments in their presentation:
None

CE Broker Code: 24R00983

ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.

TRANSCRIPT
Any credit or attendance awarded will appear on your Transcript.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.

QUESTIONS?
Contact Taylor Avrett